Author

Gerald G. Gross

Observed names: G G Gross, G. G. Gross, G. Gross, G.G. Gross, Gerald G Gross, Gerald Gross, Gross, Gerald G.

Observed institutions: Mayo Clinic, North Central Cancer Treatment Group, Sanford Medical Center, Mayo Clinic in Florida

OpenAlex ID: A5113443602

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

2008 · V. Roy, B.R. LaPlant, et al. · Annals of Oncology · 145

Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)

2020 · Hao Xie, Jacqueline M. Lafky, et al. · Therapeutic Advances in Medical Oncology · 30

Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)

2019 · Sanford Kempin, Zhuoxin Sun, et al. · Acta Haematologica · 8

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

2011 · Heidi Mc Kean, Philip J. Stella, et al. · Cancer Investigation · 6

Exposure values around an x‐ray scanning transaxial tomograph (EMI scanner)

1975 · G. Gross, E. C. McCullough · Medical Physics · 6

Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.

2000 · M M Abdel-Raheem, M G Jamil, et al. · PubMed · 5

Publishers on publishing

1961 · Gerald G Gross · Grosset & Dunlap eBooks · 5

NCCTG phase II trial N0531of weekly nab-paclitaxel (nab-p) in combination with gemcitabine (gem) in patients with metastatic breast cancer (MBC)

2007 · V. Roy, B. R. LaPlant, et al. · Journal of Clinical Oncology · 4

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance)

2022 · Kostandinos Sideras, David W Hillman, et al. · The Oncologist · 3

A phase II, multicenter evaluation of docetaxel, gemcitabine, and bevacizumab followed by bevacizumab alone in patients with locally advanced or metastatic non-small cell lung cancer (central localization excluded)

2008 · R. H. Ansari, M. A. Socinski, et al. · Journal of Clinical Oncology · 1

Randomized phase II study of two doses of pixantrone in patients with metastatic breast cancer (N1031, Alliance).

2012 · Kostandinos Sideras, Alvaro Moreno-Aspitia, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 213

H-index: 5

I10-index: 2